Is combined treatment more effective than switching to monotherapy in patients with resistant depression?
The findings of this study suggest that combined treatment is more efficacious than switch to monotherapy in the treatment of resistant depression.
Together, these findings provide a strong rationale for the early evaluation of mTOR inhibitors as a molecular targeted approach to treat SCC.